support

# Expert Assessment: SMARCA4 Targeting for Neurodegeneration

## Executive Summary

This hypothesis proposes an epigenetically targeted intervention to restore the AMPK-SIRT1-PGC1α nutrient-sensing axis, which is genuinely dysregulated in aging and neurodegeneration. The mechanistic logic is coherent, but the hypothesis carries significant translational risks that the current confidence score (0.82) likely underestimates.

**Confidence Score: 0.58** — Moderate confidence pending resolution of critical knowledge gaps

---

## Target Druggability Assessment

### SMARCA4 is Mechanistically Druggable
- **ATPase activity** represents a classical small-molecule target
- **Known chemical matter exists**: PROTAC degraders (e.g., AU-15330), catalytic inhibitors, and natural product modulators of SWI/SNF activity are documented
- **Structural characterization** of the helicase domains enables rational drug design

### Critical Druggability Concerns

| Issue | Severity | Implication |
|-------|----------|-------------|
| **Specificity** | High | SMARCA